Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis

Author:

Mahlanza Tatenda Dawn1,Manieri Maria Claudia1,Klawiter Eric C2,Solomon Andrew J3,Lathi Ellen4,Ionete Carolina5,Berriosmorales Idanis5,Severson Christopher1,Stankiewicz James1ORCID,Cabot Ann6,Elkort Michael7,Chitnis Tanuja1ORCID,Bove Riley8ORCID,Katz Joshua4,Houtchens Maria1

Affiliation:

1. Ann Romney Center for Neurological Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

2. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

3. Department of Neurology, University of Vermont Medical Center, Burlington, USA

4. Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, USA

5. Department of Neurology, University of Massachusetts, Worcester, MA, USA

6. Department of Neurology, Concord Hospital, Concord, NH, USA

7. Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

8. Weill Institute for the Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA

Abstract

Background: The importance of supporting pregnancy-related decisions in multiple sclerosis (MS) patients has increasingly been recognized and hence the need for prospective data on pregnancy and pediatric outcomes in this patient population. Objective: To assess prospective growth and developmental outcomes of infants born to mothers with multiple sclerosis (IMS). Methods: PREG-MS is a prospective multicenter cohort study in New England, United States. We followed 65 women with MS and their infants with up to 12 months consistent pediatric follow-up. Pediatric, neurologic, and demographic information was obtained via structured telephone interviews and validated with medical records. Results: No differences in infant weights and lengths with World Health Organization (WHO) 50th percentile standards were observed ( p > 0.05). However, larger head circumference (HC) measurements than WHO standards were reported in cohort infants ( p < 0.05). There was no association between HC and markers of maternal MS activity, demographic, or social factors. No irreversible pediatric developmental abnormalities were observed. Conclusion: This first prospective study on pediatric anthropometry in IMS suggests a possible increase in HC compared to WHO standards without an increase in irreversible developmental abnormalities. The observations are exploratory and require confirmation with larger prospective studies in diverse groups of MS patients.

Funder

Michelle and Christopher Rondeau

sanofi genzyme

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3